| ANWPX | TWGGX | ANWPX / TWGGX | |
| Total Expense Ratio | 0.73 | 1.08 | 68% |
| Annual Report Gross Expense Ratio | 0.73 | 1.08 | 68% |
| Fund Existence | 53 years | 27 years | - |
| Gain YTD | 19.192 | 15.947 | 120% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 163B | 630M | 25,873% |
| Annual Yield % from dividends | 0.47 | 0.08 | 601% |
| Returns for 1 year | 11.61 | -2.13 | -545% |
| Returns for 3 years | 44.28 | 12.32 | 360% |
| Returns for 5 years | 25.01 | -14.90 | -168% |
| Returns for 10 years | 92.95 | 4.55 | 2,041% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBTK | 19.89 | 0.02 | +0.10% |
| iShares iBonds Dec 2030 Term Trsry ETF | |||
| QLV | 72.53 | 0.05 | +0.07% |
| FlexShares US Quality Low Vol ETF | |||
| GLBL | 25.19 | N/A | N/A |
| Pacer MSCI World Industry Advantage ETF | |||
| MCH | 28.85 | -0.23 | -0.80% |
| Matthews China Active ETF | |||
| XBI | 118.47 | -1.38 | -1.15% |
| State Street® SPDR® S&P® Biotech ETF | |||